BriaCell Therapeutics Corp. (BCTX): Total Assets
$23.58M
As of 2026-07-31
-4.6%
3-year compound annual growth
-16.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $23.58M | +8.9% | 2026-10-28, Balance as of period end |
| 2025-07-31 | $21.65M | +268.7% | 2026-10-28, Balance as of period end |
| 2024-07-31 | $5.87M | -78.4% | 2025-10-16, Balance as of period end |
| 2023-07-31 | $27.16M | -36.2% | 2024-10-29, Balance as of period end |
| 2022-07-31 | $42.58M | -26.6% | 2023-10-25, Balance as of period end |
| 2021-07-31 | $58.04M | n/a | 2022-10-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2026-07-31 | $23.58M | +8.9% |
| Immunic, Inc. (IMUX) | 2025-12-31 | $24.05M | -41.1% |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $24.16M | -61.2% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $24.25M | -33.5% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $22.90M | -49.5% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $22.82M | +88.2% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
Compare BCTX, IMUX, RNTX, KPRX side by side · Screen every company in Pharmaceutical Preparations ↗